Steph & Co
Source: SEC Form 13F · as of Mar 2026Steph & Co holds 19 biotech & pharma companies tracked by BioSniper, totaling $4.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$4.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 3,348 | $818K |
| PMPhilip Morris International Inc | 4,701 | $777K |
| DGXQuest Diagnostics Incorporated | 3,253 | $638K |
| GILDGILEAD SCIENCES, INC. | 3,285 | $458K |
| BMYBRISTOL MYERS SQUIBB CO | 7,353 | $446K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,306 | $353K |
| ABBVAbbVie Inc. | 1,250 | $272K |
| ABTABBOTT LABORATORIES | 1,570 | $161K |
| PFEPFIZER INC | 2,120 | $60K |
| IQVIQVIA Holdings Inc. | 334 | $57K |
| CORCencora Inc. | 168 | $53K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 847 | $47K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 135 | $45K |
| BIIBBIOGEN INC. | 145 | $27K |
| ZBHZimmer Biomet Holdings Inc. | 280 | $25K |
| LLYELI LILLY & Co | 20 | $18K |
| ARGXARGENX SE | 20 | $15K |
| GMOptec International, Inc. | 100 | $7K |
| VTRSViatris Inc | 12 | $162 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.